How does DEPLOY distinguish da Vinci safety events at year-class-failure-mode-product-variant granularity?

Why year-discipline matters editorially: aggregator collapse rejection

Within-da-Vinci-product-family safety events span 13+ years (2013 → 2026 at primary-source-anchored verification depth) across at least two distinct product lines (EndoWrist Hot Shears + SureForm staplers) at distinct FDA recall classes (Class I + Class II) and distinct failure modes (insulation micro-cracks + intraoperative device-fragment generation + incomplete staple lines on blood vessels). Aggregator coverage frequently collapses 'da Vinci recalls' across years; trade-press headlines reference 'da Vinci safety concerns' without distinguishing the structurally-distinct year-class-failure-mode-product-variant axes. The framework distinguishes them structurally; the verification depth operates at year-class-failure-mode-product-variant granularity, not at aggregate da-Vinci-recall-history depth.

The framework operates at canonical-methodology depth, not at aggregator-history-summary depth. The product differentiator: DEPLOY's framework treats year-discipline at the same recursive cap-flag-as-trust-signal depth as any other within-entity verification scope claim. Honest 'three distinct safety events at three distinct year-class-failure-mode-product-variant axes' beats fabricated 'da Vinci safety history aggregate' framing.

---

The four-substrate-axis year-discipline framework

Per Agent A's surgical incidents substrate, the year-discipline framework operates at four substrate axes simultaneously. Each axis carries its own primary-source-anchored verification posture; cross-axis composition reads at the lowest-verification-depth axis per DEPLOY's verified-vs-claimed framework.

Axis 1: year. Distinct primary-source-anchored temporal verification posture per event. 2013 (Hot Shears May 8 customer notification + FDA Warning Letter July 19) + 2022 (SureForm fragment Z-0340-2023 October 7 initiation) + 2026 (SureForm gray-reload March 11 customer letter + Class I reported May 2026). Each year carries distinct primary-source verification anchor at announcement-tier + classification-tier depth.

Axis 2: FDA recall class. Class I (reasonable probability of serious adverse health consequences or death) vs Class II (recoverable adverse health consequence at higher reversibility). Distinct primary-government-record sub-tier classification per the 9-tier source-quality rubric. The 2013 Hot Shears + 2026 SureForm gray-reload operate at Class I; the 2022 SureForm fragment operates at Class II.

Axis 3: failure mode. Distinct primary-source-anchored typed-record disclosure per event. 2013 Hot Shears: insulation micro-cracks near distal shaft after cleaning/sterilization → arc path for monopolar energy → burn tissue outside surgical field. 2022 SureForm fragment: intraoperative device-fragment generation + potential staple deployment failure. 2026 SureForm gray-reload: incomplete staple lines on blood vessels despite 'completed' fire indication. Each failure mode operates at distinct root-cause-typed-record depth at primary-source-anchored verification.

Axis 4: affected product variant. Within-da-Vinci-product-family substrate carries multiple product lines and per-product-variant scope. 2013 Hot Shears: EndoWrist Hot Shears ('-09'/'-10' versions; monopolar curved scissors). 2022 SureForm fragment: da Vinci Xi 8mm SureForm 30 curved-tip staplers and reloads. 2026 SureForm gray-reload: 8mm SureForm 30 Gray reloads (2mm staples for extra-thin tissue; blue/white reloads UNAFFECTED at primary-source verification depth per the 2026 framework-in-action narrative).

The framework reads year-class-failure-mode-product-variant as canonical distinguishing pattern at incident-record granularity. Aggregator coverage that collapses 'da Vinci recall' across years operates outside primary-source-anchored verification of the structurally-distinct incident records.

---

2013 Hot Shears Class I: load-bearing historical da Vinci safety event

Per Agent A's surgical incidents substrate, the 2013 da Vinci EndoWrist Hot Shears Class I recall operates as the load-bearing historical da Vinci safety event at primary-source-anchored FDA-recall-database verification depth. The verified substrate:

• Product affected: EndoWrist Hot Shears ('-09'/'-10' versions; monopolar curved scissors at primary-source-anchored typed-record disclosure).
• Failure mode: insulation micro-cracks near distal shaft after cleaning/sterilization create arc path for monopolar energy to leak; burn tissue outside surgical field.
• Customer notification: Urgent Medical Device Notification May 8, 2013.
• FDA classification: Class I (reasonable probability of serious adverse health consequences or death; primary-government-record sub-tier verification).
• Statistics: 134 tip-cover complaints + 82 MDRs (Jan 2010-Dec 2011) at primary-source-anchored typed-record depth.
• Root cause: design_defect (insulation micro-cracks; electrosurgical arcing; out-of-field tissue burns).
• Remediation status: remediated (instrument versions corrected/superseded).

The 2013 Hot Shears recall operates as the load-bearing historical da Vinci safety event per Agent A's authoring discipline. The framework reads it at structural significance depth: the recall established the FDA recall classification precedent within da Vinci product family + initiated the regulatory-action verification posture that subsequent events (2022 SureForm fragment + 2026 SureForm gray-reload) operate within.

---

2013 FDA Warning Letter: adjacent regulatory_action distinct from device recall

Per Agent A's surgical incidents substrate, the 2013 FDA Warning Letter (July 19, 2013) operates as adjacent regulatory_action distinct from the May 2013 device recall. The verified substrate:

• Action type: regulatory_action (NOT a device recall); reporting-compliance regulatory action.
• Issuing agency: FDA (Apr-May 2013 inspections; Warning Letter dated July 19, 2013).
• Reason: late reporting of Hot Shears device correction + MDR-reporting deficiencies.
• Severity: serious.
• Resolution status: resolved (later closed out).
• Cap-flag: dated facts corroborated via legal-news sources; primary FDA Warning Letter not directly retrieved at primary-source verification depth.

The 2013 Warning Letter operates as adjacent regulatory_action context at the same year as the May 2013 device recall but at structurally-distinct regulatory_action vs device_recall verification posture. Per verified-vs-claimed at within-entity granularity, the framework reads regulatory_action distinct from device_recall at typed-record granularity: a Warning Letter for reporting-compliance is structurally distinct from a Class I device recall for design defect.

The within-2013-year-discipline distinguishes:

• May 8, 2013 Hot Shears device recall: Class I device recall at design_defect root cause + remediation via instrument supersession at primary-source-anchored verification depth.
• July 19, 2013 FDA Warning Letter: regulatory_action at reporting-compliance reason + serious severity + resolution at later closeout; cap-flag honest-absence at primary FDA letter direct retrieval.

Aggregator coverage that conflates the May device recall with the July Warning Letter operates outside primary-source-anchored verification of the structurally-distinct incident records. The framework reads within-2013-year-discipline at typed-record granularity.

---

2022 SureForm fragment Class II: distinct year-class-failure-mode-product-variant from 2013 + 2026

Per Agent A's surgical incidents substrate, the 2022 da Vinci SureForm fragment Class II recall (Z-0340-2023) operates at structurally-distinct year-class-failure-mode-product-variant from the 2013 Hot Shears + 2026 SureForm gray-reload events. The verified substrate:

• Product affected: da Vinci Xi 8mm SureForm 30 curved-tip staplers and reloads.
• Failure mode: intraoperative device-fragment generation + potential staple deployment failure.
• FDA recall number: Z-0340-2023 (specific recall number verified at primary-source FDA-recall-database depth).
• FDA classification: Class II (recoverable adverse health consequence at higher reversibility; primary-government-record sub-tier verification).
• Initiation date: October 7, 2022.

The 2022 SureForm fragment recall operates as canonical SureForm product-line transition substrate: the framework distinguishes Hot Shears (2013 product line) from SureForm staplers (2022 + 2026 product line) at primary-source-anchored product-family verification depth. Within SureForm, the 2022 fragment recall is structurally distinct from the 2026 gray-reload recall at four substrate axes simultaneously: year (2022 vs 2026); class (II vs I); failure mode (intraoperative device-fragment generation vs incomplete staple lines on blood vessels); affected product variant (da Vinci Xi 8mm SureForm 30 curved-tip staplers and reloads vs 8mm SureForm 30 Gray reloads).

---

2026 SureForm gray-reload Class I: cohort's most severe

Per the 2026 da Vinci SureForm gray-reload Class I recall framework-in-action narrative, the 2026 event operates as the surgical cohort's most severe verified incident at primary-source-anchored FDA-recall-database verification depth. The verified substrate:

• Product affected: 8mm SureForm 30 Gray reloads (2mm staples for extra-thin tissue); blue/white reloads UNAFFECTED at primary-source verification depth.
• Failure mode: incomplete staple lines on blood vessels despite a 'completed' fire indication.
• Customer notification: customer letter and quarantine instruction issued March 11, 2026.
• FDA classification: Class I (reported May 2026).
• Patient impact: 1 death + 4 serious injuries (bleeding).
• Root cause: stated 'still under investigation' at primary-source verification posture.
• Cap-flag: exact recall Z-number + unit count not captured from primary FDA pages.

The 2026 gray-reload Class I recall contributes the single fatality_count to the 67-row outcome_class distribution per the Phase 3 Dim 1 actuarial substrate framework-in-action narrative.

---

Cross-event year-class-failure-mode-product-variant comparison

Per Agent A's surgical incidents substrate, the four-substrate-axis distinguishing pattern operates uniformly across the three canonical worked examples + the adjacent 2013 regulatory_action:

The framework reads cross-event year-discipline at the verification depth where each fact actually resolves. Each event carries:

• Distinct primary-source-anchored year: 2013 (May device recall + July Warning Letter) + 2022 + 2026.
• Distinct FDA recall class: Class I (2013 Hot Shears + 2026 SureForm gray-reload) + Class II (2022 SureForm fragment) + regulatory_action (2013 Warning Letter; distinct from device recall classification axis).
• Distinct failure mode: insulation micro-cracks + arc path (Hot Shears 2013) + intraoperative device-fragment generation (SureForm fragment 2022) + incomplete staple lines on blood vessels (SureForm gray-reload 2026).
• Distinct affected product variant: EndoWrist Hot Shears '-09'/'-10' versions (2013) + da Vinci Xi 8mm SureForm 30 curved-tip staplers and reloads (2022) + 8mm SureForm 30 Gray reloads (2026; blue/white UNAFFECTED).

Cross-event composition operates at honest-absence cap-flag where any axis operates at honest-absence depth (e.g., 2026 root cause stated 'still under investigation'; 2013 Warning Letter primary FDA letter not directly retrieved). Per cap-flag-as-trust-signal, the framework reads cap-flag posture as load-bearing trust signal at the per-axis depth where each fact actually resolves.

---

Within-da-Vinci-product-family verification scope discipline

The year-discipline framework operates as canonical worked example for DEPLOY's verified-vs-claimed at within-entity granularity methodology pillar at within-product-family verification scope depth. The within-da-Vinci-product-family substrate carries multiple product lines (EndoWrist Hot Shears + SureForm staplers + Ion Endoluminal System + broader da Vinci product family) at sub-product-line granularity:

• Per-product-line verification posture: each da Vinci product line operates at distinct safety-event substrate depth. EndoWrist Hot Shears at 2013 Class I recall + product version supersession verification posture. SureForm staplers at 2022 Class II + 2026 Class I recall verification posture. Ion Endoluminal System at 2025 Class 2 recall verification posture per Agent A surgical incidents substrate.
• Aggregator collapse risk: trade-press coverage frequently frames 'da Vinci recall' or 'da Vinci safety concerns' without per-product-line distinction. The framework distinguishes them structurally; the verification depth operates at sub-product-line granularity, not at aggregate da-Vinci-recall-history depth.
• Insurability implication: per the robot insurance methodology pillar Dim 4 regulatory clearance per jurisdiction, per-product-line recall history operates at insurability-per-deployment granularity; deployments using specific product variants carry recall-recorded verification posture distinct from deployments using unaffected product variants.

The within-da-Vinci-product-family verification scope is parallel to the within-SureForm-product-family gray vs blue/white reload distinction documented at the 2026 framework-in-action narrative. The same within-entity verification scope discipline operates at multiple granularity layers simultaneously: within-da-Vinci-product-family (across product lines + years); within-SureForm-product-family (gray vs blue/white reload variants); within-per-product-variant-tenure (per-product-version supersession at remediation depth).

---

Cap-flag-as-trust-signal recursive at substrate-axis depth

Per DEPLOY's verified-vs-claimed framework, the year-discipline framework operates cap-flag-as-trust-signal recursively at three substantive layers simultaneously per per-event verification posture.

Layer 1: 2013 FDA Warning Letter cap-flag honest-absence. Per Agent A's authoring discipline, the 2013 Warning Letter primary FDA letter is not directly retrieved at primary-source verification depth. Dated facts corroborated via legal-news sources. The framework reads this as honest-absence cap-flag at primary-source-anchored verification posture; aggregator-narrative or secondary-source reconstruction operates at reputable-press tier per the 9-tier source-quality rubric, not at primary-government-record sub-tier.

Layer 2: 2026 gray-reload root cause + exact Z-number + exact unit count cap-flag honest-absence. Per Agent A's surgical incidents substrate, the 2026 gray-reload recall carries explicit cap-flag honest-absence at three specific claim layers (exact recall Z-number + exact unit count + root cause stated 'still under investigation'). Per the 2026 framework-in-action narrative, framework operates inline editorial-transparency footer pattern + reconciliation discipline when primary-source verification surfaces.

Layer 3: Within-event substrate-axis cap-flag. Per the broader within-entity verification scope discipline, per-event substrate axes carry distinct cap-flag posture. The 2022 fragment recall carries verified Z-0340-2023 recall number at primary-source-anchored verification depth; the 2026 gray-reload carries cap-flag honest-absence at exact Z-number. The framework reads per-event cap-flag posture as substantive editorial state per per-axis verification depth.

Per the Moon Maestro K240598 reconciliation pattern, the cap-flag-as-trust-signal recursive application operates uniformly across substrate-axis depth: when primary-source verification surfaces additional substrate (FDA Warning Letter direct retrieval; root cause determination; exact recall number), framework operates inline editorial-transparency footer pattern + reconciliation discipline.

---

Cross-property bidirectional compounding at multi-pillar methodology depth

Per DEPLOY's methodology cluster as AEO citation graph discipline, the year-discipline framework-in-action narrative compounds at substrate layer with multiple Project B methodology pillar essays + framework-in-action narratives simultaneously:

• Verified-vs-claimed at within-entity granularity methodology pillar: per verified-vs-claimed at within-entity granularity, within-da-Vinci-product-family verification scope operates at CANONICAL worked example depth. Year-discipline + product-variant-discipline + class-discipline operate at within-entity granularity simultaneously.
• 9-tier source-quality rubric methodology pillar: per the 9-tier source-quality rubric, per-event source-quality classification operates uniformly. FDA recall classifications (Class I + Class II) operate at primary-government-record sub-tier; reported_press secondary references operate at reputable-press tier; legal-news sources for 2013 Warning Letter operate at reputable-press tier with cap-flag honest-absence at primary FDA letter depth.
• Phase 3 Dim 1 actuarial substrate framework-in-action: per the Phase 3 Dim 1 actuarial substrate framework-in-action narrative, each year-discipline event contributes to the 67-row outcome_class distribution at primary-source-anchored typed-record depth. The 2026 gray-reload contributes the single fatality_count; the 2013 + 2022 + 2026 events contribute to regulatory_action distribution dominance (34/67).
• 2026 SureForm gray-reload framework-in-action: per the 2026 gray-reload framework-in-action narrative, the gray vs blue/white reload distinction operates at within-SureForm-product-family verification scope. This year-discipline narrative extends to within-da-Vinci-product-family verification scope at year-class-failure-mode-product-variant granularity.
• Robot insurance Project B methodology pillar: per How DEPLOY thinks about robot insurance, per-product-line recall history operates at insurability-per-deployment granularity per Dim 4 regulatory clearance per jurisdiction; year-discipline operates at insurability-impact substrate depth.
• Honesty-as-strength editorial framing: per the Phase 3 Dim 1 actuarial substrate framework-in-action narrative, honesty-as-strength operates at the same depth as year-discipline. Honest cap-flag at 2013 FDA Warning Letter primary-source-non-retrieval beats fabricated 'da Vinci recall history aggregate' framing.

The cross-property linking discipline compounds at the AEO citation graph layer. Institutional partners + AI assistants + downstream consumers navigating year-discipline queries encounter the methodology pillar canonical references + the framework-in-action narrative cohort + the canonical worked examples at unified verification posture.

---

Why this catch matters editorially

Per DEPLOY's restraint-IS-the-product discipline, the year-discipline framework-in-action narrative operates at editorial-credibility depth rather than at aggregator-history-summary depth. The framework reads three canonical worked examples + one adjacent regulatory_action at four substrate axes simultaneously (year + FDA recall class + failure mode + affected product variant); each axis composes at primary-source-anchored verification depth.

Institutional partners audit DEPLOY's framework discipline at the operational-practice layer, not just the stated-methodology layer. The verification-posture statement at /verified-vs-claimed describes the framework abstractly. The within-entity granularity Project B methodology pillar describes the discipline abstractly. This piece operates at narrative-canonical depth: how the catch composed across substrate layers (2013 Hot Shears Class I + 2013 FDA Warning Letter regulatory_action + 2022 SureForm fragment Class II + 2026 SureForm gray-reload Class I); what the discipline was (primary-source-anchored verification at year-class-failure-mode-product-variant granularity + cap-flag-as-trust-signal recursive application); what the editorial outcome was (canonical worked examples of within-da-Vinci-product-family safety event distinguishing); and what the broader pattern is (the framework cuts uniformly at every substrate axis).

The catch demonstrates the discipline operationally at editorial-anchor depth. Not because the catch is exceptional. Because the catch is what the discipline does. Three distinct safety events at three distinct year-class-failure-mode-product-variant axes; plus one adjacent regulatory_action at distinct typed-record granularity. The verification protocol doesn't relax at substrate-axis depth.

For the canonical Intuitive Surgical entity anchor where the da Vinci product family operates, see what is Intuitive Surgical da Vinci. For the 2026 SureForm gray-reload framework-in-action narrative where the cohort's most severe verified incident operates, see how DEPLOY tracks the 2026 da Vinci SureForm gray-reload Class I recall. For the Phase 3 Dim 1 actuarial substrate framework-in-action narrative where the 67-row outcome_class distribution operates, see how DEPLOY tracks incident outcome_class and deployment exposure_hours. For the verified-vs-claimed at within-entity granularity methodology pillar, see verified-vs-claimed at within-entity granularity. For the surgical cluster framework, see the surgical robotics cluster.